Femoropopliteal bypass is the traditional management of superficial femoral artery lower extremity athero-occlusive disease for lifestyle-limiting claudication and critical limb ischemia. Over the last decade, with the advent of new technologies, an increasing number of endovascular interventions are being used to treat femoropopliteal disease. Endovascular interventions are attractive to patients and physicians because of their decreased morbidity and mortality, despite the possibility of reduced durability. A multitude of techniques are available, without a clear consensus as to which one is best. This article reviews the current endovascular management options available for femoropopliteal occlusive disease, and the published results with each modality.